Biotechnology
Medicare will pay for Alzheimer’s drug Leqembi. What patients and doctors should know
The Alzheimer’s drug Leqembi is seen in this undated handout image obtained by Reuters on January 20, 2023. Eisai | via Reuters Medicare has agreed to pay for the Alzheimer’s treatment Leqembi, a major turning point for patients who are diagnosed with the early stages of the disease. Leqembi is the only drug on the […]
Read More
Sales of Alzheimer’s drug Leqembi may be slow initially but could pick up in 2024
Jay Reinstein, who suffers from Alzheimer’s, receives an injection so he can have a PET scan at MedStar Georgetown University Hospital in Washington, DC on June 20, 2023. Michael Robinson Chávez | The Washington Post | Getty Images Sales of the Alzheimer’s drug Leqembi may be slow initially due to logistical requirements but could pick […]
Read More
FDA approves Alzheimer’s drug Leqembi, paving way for broader Medicare coverage
The Food and Drug Administration on Thursday approved the Alzheimer’s treatment Leqembi, a pivotal decision that is expected to expand access to the expensive drug for older Americans. Medicare has promised to start covering Leqembi, with some conditions, on the same day the FDA approves the antibody treatment. Leqembi is made by Japanese pharmaceutical company […]
Read More
Moderna strikes deal to develop mRNA drugs in China
Nikos Pekiaridis | Nurphoto | Getty Images Moderna on Wednesday said it struck a deal with Chinese officials to research, develop and manufacture messenger RNA medicines in the country, despite rising tensions between the U.S. and China. The Massachusetts-based biotech company signed a memorandum of understanding and a related land collaboration deal to develop drugs […]
Read More
Medicare will allow pharmaceutical companies to publicly discuss drug price negotiations
Hundreds of 1199SEIU health care workers staged a rally and sit to block 3rd avenue where some were arrested. They protested against health care cuts in Governor Kathy Hochuls budget on Medicare. Lev Radin | Lightrocket | Getty Images Medicare on Friday said it will allow pharmaceutical companies to publicly discuss the program’s historic drug […]
Read More
People should stop taking Ozempic, Wegovy obesity drugs before surgery, doctors group says
In this photo illustration, a box of the diabetes drug Ozempic rests on a pharmacy counter on April 17, 2023 in Los Angeles, California. Mario Tama | Getty Images People on diabetes and weight loss drugs such as Novo Nordisk‘s Ozempic and Wegovy should stop taking them before having elective surgery to reduce the risk […]
Read More
The to start with absolutely A.I.-produced drug enters scientific trials in human individuals
Alex Zhavoronkov, left, founder and CEO of Insilico Medication, and Feng Ren, co-CEO and main scientific officer, at the firm’s robotics lab in Suzhou, China. Resource: Insilico Medication The very first drug completely created by synthetic intelligence entered medical trials with human clients this 7 days. Insilico Medication, a Hong Kong-centered biotech startup with extra […]
Read More
Hepatitis C cure is not reaching overwhelming majority of patients due to financial barriers
Hepatitis C virus BSIP | UIG | Getty Images The overwhelming majority of people in the U.S. who have tested positive for hepatitis C have not been cured due to the high cost of oral antiviral treatments and obstacles imposed by insurance plans, federal health officials said on Thursday. Hepatitis C is often referred to […]
Read More
Ex-Pfizer employee charged with illegal trading based on unreleased Covid pill trial data
Federal authorities charged a former Pfizer employee and his close friend Thursday with illegally trading shares based on non-public trial results on the pharmaceutical company’s Covid antiviral pill Paxlovid. The Justice Department and the Securities and Exchange Commission both announced respective insider trading charges against Amit Dagar, a former senior statistical programming lead at Pfizer, […]
Read More
CDC recommends RSV vaccines from Pfizer, GSK for adults 60 and older
Respiratory syncytial virus vial. Manjurul | Istock | Getty Images The Centers for Disease Control and Prevention on Thursday recommended that adults ages 60 and above receive a single dose of RSV vaccines from Pfizer and GSK after consulting their doctors. Outgoing CDC Director Rochelle Walensky signed off on the recommendation, which an advisory panel […]
Read More